These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19685701)

  • 1. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pompe's disease. Part II. Treatment strategies and enzyme replacement].
    Illés Z; Várdi Visy K
    Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
    Willemsen MA; Jira PE; Gabreëls FJ; van der Ploeg AT; Smeitink JA
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1388-92. PubMed ID: 9752027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].
    Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.
    Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT
    Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late infantile form of Pompe's disease. Deficiency of alpha-1,4-glucosidase (acid maltase)].
    Colomer J; Roig M; Campistol J; Rullan G; Fernández-Alvarez E
    An Esp Pediatr; 1984 Sep; 21(3):250-9. PubMed ID: 6391315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset Pompe's disease.
    Teener JW
    Semin Neurol; 2012 Nov; 32(5):506-11. PubMed ID: 23677658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.
    Hagemans ML; Winkel LP; Van Doorn PA; Hop WJ; Loonen MC; Reuser AJ; Van der Ploeg AT
    Brain; 2005 Mar; 128(Pt 3):671-7. PubMed ID: 15659425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pompe's disease--acid alpha-glucosidase deficiency--a review].
    Iwamasa T; Chinen K; Hirayasu T
    Nihon Rinsho; 1993 Sep; 51(9):2324-9. PubMed ID: 8411709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy in Pompe's disease.
    Fayssoil A
    Eur J Intern Med; 2008 Jan; 19(1):57-9. PubMed ID: 18206603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respiratory distress in infants with Pompe's disease].
    Khémiri M; Zayani M; Bou Yahya O; Zouari S; Ben Mansour F; Caillaud C; Khaldi F; Barsaoui S
    Tunis Med; 2008 Jun; 86(6):612-4. PubMed ID: 19216463
    [No Abstract]   [Full Text] [Related]  

  • 15. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
    Katzin LW; Amato AA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited.
    Schoser BG; Müller-Höcker J; Horvath R; Gempel K; Pongratz D; Lochmüller H; Müller-Felber W
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):544-59. PubMed ID: 17573812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
    Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study of alglucosidase alfa in late-onset Pompe's disease.
    van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA
    N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural course of non-classic Pompe's disease; a review of 225 published cases.
    Winkel LP; Hagemans ML; van Doorn PA; Loonen MC; Hop WJ; Reuser AJ; van der Ploeg AT
    J Neurol; 2005 Aug; 252(8):875-84. PubMed ID: 16133732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse.
    Kamphoven JH; de Ruiter MM; Winkel LP; Van den Hout HM; Bijman J; De Zeeuw CI; Hoeve HL; Van Zanten BA; Van der Ploeg AT; Reuser AJ
    Neurobiol Dis; 2004 Jun; 16(1):14-20. PubMed ID: 15207257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.